Clinical trial Recruiting at 1 site Interventional Ages 18 and up

TBI-RECOVER in Outpatient Substance Use Treatment

Official title: Facilitation as a Strategy for Implementing the Novel TBI-RECOVER Intervention Into Substance Use Treatment: A Mixed Methods Hybrid Type 2 Effectiveness-Implementation Trial

Run by Ohio State University · NCT07215221 · Data updated 2026-11-12

This trial tests whether the TBI-RECOVER program can help people with a substance use disorder who have a brain injury, by improving retention in treatment and managing cognitive and behavioral challenges.

More Traumatic Brain Injury trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment900 (estimated)
SponsorOhio State University
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedApril 28, 2026
Main results expectedJanuary 30, 2030
Study endsMarch 30, 2030
Registry record updatedJuly 7, 2026
Trial IDNCT07215221 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

English-speaking adults with a diagnosed substance use disorder receiving outpatient psychotherapy at participating OSU clinics.

Probably not a fit

Patients who do not have a substance use disorder, do not have a diagnosed brain injury, or are not receiving outpatient psychotherapy may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This hybrid type 2 pilot study examines both the implementation and the effectiveness of the TBI-RECOVER intervention within outpatient SUD treatment settings. It tests a bundle of strategies—training, champions, audit and feedback, and facilitation—to support providers in delivering brain injury and cognitive screening, along with neurocognitive accommodations. The goal is to see if these practices increase provider use and sustainment and, in turn, improve patient symptoms and treatment retention. The study is conducted within the Ohio State University system in Columbus, with NIDA as a collaborator. Eligible participants are English-speaking adults with SUD assigned to outpatient psychotherapy; all treatment providers at participating clinics may participate.

Why it matters

Potential benefit: If successful, patients may experience better symptom management and higher retention in outpatient substance use treatment.

How similar studies have gone: Previous work on implementation bundles and brain injury screening in SUD care suggests potential benefits, but this exact approach is being tested in a hybrid type 2 design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patient Inclusion Criteria:

* English-speaking; diagnosed with a substance use disorder; assigned to an outpatient provider for psychotherapy at the treatment clinic participating in the study.

Patient Exclusion Criteria:

* None

Provider Inclusion Criteria:

\- All providers employed in the outpatient treatment clinic who deliver psychotherapy are eligible (e.g., social workers, counselors, psychologists).

Where it's running

  • OSU Hospital System
    Columbus, Ohio, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.